PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 8497622

Interventional radiologists: occupational radiation doses and risks.

L T Niklason·M V Marx·H P Chan
View original source ↗Export metadata ↓

Abstract

Interventional radiologists receive nonuniform occupational radiation doses, with relatively high doses to the head and extremities and low doses to the trunk, which is protected by a lead apron. Twenty-eight interventional radiologists from 17 institutions wore thermoluminescent dosimeters over their collars and under their aprons for a 2-month period. The estimated annual radiation dose was converted to effective dose as suggested by the International Commission on Radiological Protection. Effective dose is used to relate the risk associated with nonuniform dose to that associated with an equivalent uniform whole-body dose. The mean annual effective dose was 3.16 mSv (316 mrem), with a range of 0.37-10.1 mSv. The mean annual effective dose is approximately equal to the mean natural background dose of 3 mSv per year from radon and other natural sources and is only 6% of the National Council on Radiation Protection and Measurements' recommended effective dose equivalent limit of 50 mSv per year. The annual radiation risk of fatal cancer would be less than one per 10,000 for almost the entire career of an interventional radiologist.

Explore related subjects

HumansOccupational ExposureRadiation DosageRadiation ProtectionRadiology, InterventionalRisk FactorsThermoluminescent DosimetryJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

L T Niklason, M V Marx, H P Chan. 1993. Interventional radiologists: occupational radiation doses and risks.. https://doi.org/10.1148/radiology.187.3.8497622

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2027

Global Genomic Surveillance.

Global genomic surveillance has emerged as a foundational pillar of public health in the twenty-first century, enabling real-time tracking of pathogen evolution and informing outbreak response. This chapter examines the strategic architecture of global genomic surveillance, focusing on its application to arboviruses such as chikungunya virus (CHIKV). It explores the integration of genomic data with epidemiological, clinical, and environmental information within a One Health framework, while addressing critical challenges in governance, equity, and interoperability. The discussion covers the entire genomic surveillance workflow, from sample collection and sequencing to bioinformatic analysis and phylogenetic inference, and highlights the transformative role of artificial intelligence (AI) in predictive surveillance. By analyzing global initiatives, operational barriers, and emerging technologies, this chapter underscores the necessity of sustainable, equitable, and interoperable genomic systems to proactively address current and future infectious disease threats.

Humans↗
PubMed2027

Systematic Dissection of Key Driver Perturbation Signatures in Single Cells via ECCITE-seq.

CRISPR screens, such as expanded CRISPR-compatible cellular indexing of transcriptomes and epitopes by sequencing (ECCITE-seq), enable the simultaneous measurement of transcriptomes, gRNA identity, and cell-surface protein expression at single-cell resolution to systematically interrogate gene function. This platform provides a powerful and scalable experimental approach for validating disease-associated regulators identified by large-scale association studies and other computational methods, including network-based analyses of multi-omics data. Here, as an example application, we describe an ECCITE-seq framework to characterize the transcriptomic consequences of perturbing multiple neuronal key driver genes associated with Alzheimer's disease (AD) in human-induced pluripotent stem cell (hiPSC)-derived neurons. More broadly, by integrating customized pooled gRNA libraries with different CRISPR effectors across multiple cell types, this approach allows for the assessment of the regulatory impact of candidate genes implicated in development and disease processes.

Humans↗
PubMed2027

Identification of Genome-Wide Chromatin Structural Aberration in Cancer by Hi-C Analysis.

Aberrant three-dimensional genome organization is a hallmark of cancer, often driving oncogene activation through mechanisms such as enhancer hijacking. High-throughput chromosome conformation capture (Hi-C) maps these interactions on a genome-wide scale. Unlike earlier dilution-based methods, in situ Hi-C performs proximity ligation within intact nuclei, minimizing random ligation noise and enabling fine-scale structure detection. This chapter describes an optimized in situ Hi-C protocol tailored for cancer cell lines using MboI digestion and biotin-mediated pull-down to generate high-complexity libraries. We further outline a computational workflow that extends beyond standard topological mapping of compartments and topologically associating domains to identify cancer-specific aberrations. Specifically, we focus on detecting chromosomal rearrangements (structural variants) and characterizing the distinct circular topology of extrachromosomal DNA. This integrated experimental and analytical framework provides the necessary tools to dissect the spatial dysregulation underlying tumor evolution.

Humans↗